ClinicalTrials.gg
CompletedNCT07202013CELLTAPEUpdated Oct 1, 2025

Pilot Trial of Kinesio Taping in Stage II Cellulite

An interventional study of Kinesio taping in Cellulite of Thighs, sponsored by Klaipedos valstybine kolegija. Completed at 1 site in Lithuania. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Klaipedos valstybine kolegija · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Dec 2024, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to evaluate whether kinesio taping can improve skin structure and reduce stage II cellulite in women. The study focuses on adult female participants aged 18-45 with stage II cellulite and normal BMI.

The main questions it aims to answer are:

Does kinesio taping increase dermis density? Does kinesio taping improve low echogenic band (LEB) thickness, an ultrasound marker of skin structure? Researchers will compare an experimental group receiving weekly fan-shaped kinesio tape applications on thighs and buttocks for four weeks to a control group that receives no intervention, to see if kinesio taping improves clinical and instrumental measures of cellulite.

Participants will:

Undergo baseline and follow-up assessments, including body composition, thigh circumference, cellulite stage scoring, and ultrasound of dermis density and LEB.

In the experimental group, receive kinesio taping applied once weekly for four weeks on the buttocks and thighs.

Return for re-evaluation immediately after the intervention and four weeks later.

Read the detailed description

Cellulite is a common skin condition characterized by dimpling and irregular surface texture, primarily affecting women. It is associated with changes in the dermis and subcutaneous connective tissue, impaired microcirculation, and lymphatic congestion. Although not a disease, cellulite negatively impacts quality of life and has psychosocial consequences. Stage II cellulite, as defined by the Nürnberger-Müller Scale, presents with visible dimpling when standing, structural changes on palpation, and alterations detectable through imaging.

Kinesio taping (KT) is a non-invasive physiotherapy method widely used for musculoskeletal and circulatory conditions. Elastic tape is applied to the skin in specific patterns with the aim of lifting the epidermis, reducing local pressure, improving interstitial fluid flow, and enhancing lymphatic drainage. Based on these mechanisms, KT may be beneficial in the treatment of cellulite, particularly by improving dermal structure and promoting metabolic activity in subcutaneous fat. However, scientific evidence for KT in cellulite management remains scarce and inconsistent.

This pilot randomised controlled trial is designed to evaluate the short-term effects of kinesio taping on structural skin parameters in women with stage II cellulite. Thirty-four participants aged 18-45 years with normal body mass index and clinically confirmed stage II cellulite are randomly assigned to an experimental group or a control group. The experimental group receives fan-shaped kinesio tape applied once weekly for four weeks on the buttocks and thighs. The control group receives no intervention during the study period.

Primary outcomes include dermis density and low echogenic band (LEB) thickness measured using high-frequency ultrasound (DermaLab Combo 4). Secondary outcomes include cellulite stage scoring (Nürnberger-Müller Scale and Callegari Soft Plus), thigh circumference, body composition (fat percentage, fat mass, fat-free mass, basal metabolic rate, and total body water), and skin moisture. Measurements are taken at baseline, after four weeks of intervention, and four weeks post-intervention to assess residual effects.

The primary hypothesis is that kinesio taping will increase dermis density and LEB thickness compared with no intervention, indicating improved skin structure. Secondary hypotheses include potential reductions in thigh circumference and fat percentage and stabilization of skin hydration compared to the control group.

This study is exploratory and intended to provide pilot data on feasibility, effect sizes, and outcome variability. Findings may inform the design of larger trials and contribute to the evidence base for kinesio taping as a possible adjunctive therapy in cellulite management.

02

Conditions studied

  • Cellulite of Thighs

Browse trials for

Keywords

  • cellulite
  • Kinesio Taping
  • Skin Structure
  • Dermis Density
  • Low Echogenic Band
  • Body composition
03

In context

Cellulite

71 studies on the registry are indexed under Cellulite; 3 are open to participants now.

This study's enrollment of 34 is close to the median of 34 across 65 interventional studies indexed under Cellulite.

Browse Cellulite studies →

Lead sponsor

This is the only study on the registry with Klaipedos valstybine kolegija as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women,
  • aged 18-45,
  • with Stage II cellulite,
  • normal

Exclusion criteria

Exclusion Criteria:

  • pregnancy,
  • edema,
  • obesity,
  • thrombosis,
  • skin infections
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Kinesio taping

    Participants received kinesio taping once weekly for four weeks. Fan-shaped elastic therapeutic tape was applied with 0-15% tension to the thighs and buttocks, including the gluteus maximus, posterior thigh, and anterior thigh, to promote lymphatic drainage, improve microcirculation, and support skin structure.

    Other: Kinesio taping

  • No intervention
    No intervention

    Participants in this arm did not receive any intervention during the study period. They completed the same baseline, post-intervention (4 weeks) assessments as the experimental group to allow comparison of outcomes without kinesio taping.

Interventions

  • OtherKinesio taping

    Kinesio taping was applied in a fan-shaped pattern once weekly for four consecutive weeks. Elastic therapeutic tape was applied with 0-15% tension to the buttocks and thighs at standardized anatomical points, including the gluteus maximus (above the sacroiliac joint), posterior thigh (gluteal fold), and anterior thigh (above the anterior inferior iliac crest). This protocol was designed to promote lymphatic drainage, improve microcirculation, and enhance dermal density and structure in women with stage II cellulite.

06

What researchers measure

Primary outcomes

  1. Change in Low Echogenic Band (LEB) Thickness

    LEB thickness, a subepidermal ultrasound marker of skin integrity and cellulite severity, will be measured using high-frequency ultrasound (DermaLab Combo 4).

    Time frame: Baseline to 4 weeks (end of intervention).

  2. Change in Dermis Density

    Dermis density will be assessed using high-frequency ultrasound (DermaLab Combo 4) to evaluate changes in skin structure associated with cellulite.

    Time frame: Baseline to 4 weeks (end of intervention).

Secondary outcomes

  1. Change in Thigh Circumference

    Thigh circumference measured 20 cm below the greater trochanter with participants standing relaxed, to assess reduction in girth associated with cellulite.

    Time frame: Baseline to 4 weeks (end of intervention)

  2. Change in Body Fat Percentage

    Body fat percentage will be measured by bioelectrical impedance analysis (Tanita BC-418MA).

    Time frame: Baseline to 4 weeks (end of intervention)

  3. Change in Cellulite Stage (Nürnberger-Müller Scale)

    Cellulite severity will be assessed using the Nürnberger-Müller Scale. Minimum = 0 (no cellulite) Maximum = 3 (severe cellulite) Higher scores indicate worse cellulite severity. Higher scores indicate worse cellulite severity.

    Time frame: Baseline to 4 weeks (end of intervention)

  4. Change in Cellulite Severity (Callegari Soft Plus System)

    Cellulite severity will be measured using the Callegari Soft Plus system, which provides a continuous numerical score based on skin tissue analysis. Minimum = 0 (no detectable cellulite) Maximum = 100 (severe cellulite).Higher scores indicate worse cellulite severity.

    Time frame: Baseline to 4 weeks (end of intervention)

  5. Change in Fat Mass (kg)

    Fat mass will be measured by bioelectrical impedance analysis (Tanita BC-418MA).

    Time frame: Baseline to 4 weeks (end of intervention)

  6. Change in Fat-Free Mass (Kg)

    Fat-free mass will be measured by bioelectrical impedance analysis (Tanita BC-418MA).

    Time frame: Baseline to 4 weeks (end of intervention)

  7. Change in Basal Metabolic Rate (kcal/day)

    Basal metabolic rate will be measured by bioelectrical impedance analysis (Tanita BC-418MA).

    Time frame: Baseline to 4 weeks (end of intervention)

  8. Change in Total Body Water (%)

    Total body water will be measured by bioelectrical impedance analysis (Tanita BC-418MA).

    Time frame: Baseline to 4 weeks (end of intervention)

07

Study locations

1 site
  • Klaipedos valstybine kolegija
    Klaipėda, Lithuania
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07202013
Lead sponsor
Klaipedos valstybine kolegija
Responsible party
Sponsor
First posted
Oct 1, 2025
Start date
Dec 1, 2024
Primary completion
Feb 28, 2025
Completion
May 31, 2025
Last update
Oct 1, 2025

Study contacts

Laura Zaliene, PhD
principal investigator · Klaipedos valstybine kolegija

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion